MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with M

Methotrexate

Methotrexate 2.5mg tablets

Incompatible

Stability notes for Methotrexate 2.5mg tablets

Tablets are cytotoxic. Not recommended due to handler risk.

Suppliers (10) of Methotrexate 2.5mg tablets
Methotrexate 2.5mg tablets (A A H Pharmaceuticals Ltd)
Methotrexate 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Methotrexate 2.5mg tablets (Almus Pharmaceuticals Ltd)
Methotrexate 2.5mg tablets (Cipla EU Ltd)
Methotrexate 2.5mg tablets (Medihealth (Northern) Ltd)
Methotrexate 2.5mg tablets (Morningside Healthcare Ltd)
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
Methotrexate 2.5mg tablets (Sandoz Ltd)
Methotrexate 2.5mg tablets (Sigma Pharmaceuticals Plc)
Methotrexate 2.5mg tablets (Teva UK Ltd)

Methotrexate 10mg tablets

Incompatible

Stability notes for Methotrexate 10mg tablets

Tablets are cytotoxic. Not recommended due to handler risk.

Suppliers (5) of Methotrexate 10mg tablets
Methotrexate 10mg tablets (A A H Pharmaceuticals Ltd)
Methotrexate 10mg tablets (Alliance Healthcare (Distribution) Ltd)
Methotrexate 10mg tablets (Medihealth (Northern) Ltd)
Methotrexate 10mg tablets (Orion Pharma (UK) Ltd)
Methotrexate 10mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.